WHAT IS THE REAL IMPACT OF DEPRESSION ON CLINICAL RESPONSE TO THERAPY IN PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS?

被引：0
|
作者：
Martins, A. [1 ,2 ]
Oliveira, D. Santos [1 ,2 ,3 ]
Nicolau, R. [2 ,4 ]
Martins-Rocha, T. [1 ,2 ]
Bernardo, A. [1 ]
Pimenta, S. [1 ,2 ]
Bernardes, M. [1 ,2 ]
Costa, L. [1 ]
机构：
[1] Sao Joao Univ Hosp Ctr, Rheumatol, Porto, Portugal
[2] Univ Porto FMUP, Fac Med, Med, Porto, Portugal
[3] Univ Porto FMUP, Fac Med, CINTESIS, Porto, Portugal
[4] Ctr Hosp Tondela Viseu, Epe, Rheumatol, Viseu, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.1101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1129 / 1129
页数：1
相关论文
共 50 条
  • [1] What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?
    Ana Martins
    Daniela Oliveira
    Rafaela Nicolau
    Teresa Martins Rocha
    Alexandra Bernardo
    Lúcia Costa
    Sofia Pimenta
    Miguel Bernardes
    Clinical Rheumatology, 2024, 43 : 251 - 258
  • [2] What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?
    Martins, Ana
    Oliveira, Daniela
    Rocha, Teresa Martins
    Bernardo, Alexandra
    Costa, Lucia
    Pimenta, Sofia
    Bernardes, Miguel
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 251 - 258
  • [3] Correction to: What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs?
    Ana Martins
    Daniela Oliveira
    Rafaela Nicolau
    Teresa Martins Rocha
    Alexandra Bernardo
    Lúcia Costa
    Sofia Pimenta
    Miguel Bernardes
    Clinical Rheumatology, 2024, 43 : 1275 - 1275
  • [4] What is the association of depression with clinical response to therapy in patients with psoriatic arthritis treated with biologic disease-modifying antirheumatic drugs? (vol 43, pg 251, 2023)
    Martins, Ana
    Oliveira, Daniela
    Nicolau, Rafaela
    Rocha, Teresa Martins
    Bernardo, Alexandra
    Costa, Lucia
    Pimenta, Sofia
    Bernardes, Miguel
    CLINICAL RHEUMATOLOGY, 2024, 43 (03) : 1275 - 1275
  • [5] BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PSORIATIC ARTHRITIS: A REAL-WORLD COHORT OF 439 PATIENTS
    Letarouilly, J-G
    Salmon, J. -H.
    Coquerelle, P.
    Goeb, V.
    Guyot, M. -H.
    Houvenagel, E.
    Maury, F.
    Marguerie, L.
    Morel, G.
    Baudens, G.
    Solau-Gervais, E.
    Ramdane, N.
    Flipo, R. -M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 373 - 373
  • [6] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis
    Marguerie, L
    Flipo, RM
    Grardel, B
    Beaurain, D
    Duquesnoy, B
    Delcambre, B
    JOINT BONE SPINE, 2002, 69 (03) : 275 - 281
  • [7] An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis
    So, Anthony
    Inman, Robert Davies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 453 - 471
  • [8] Evaluation of Response Criteria in Rheumatoid Arthritis Treated With Biologic Disease-Modifying Antirheumatic Drugs
    Inoue, Mariko
    Kanda, Hiroko
    Tateishi, Shoko
    Fujio, Keishi
    ARTHRITIS CARE & RESEARCH, 2020, 72 (07) : 942 - 949
  • [9] BONE STATUS OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Miladi, S.
    Ben Ayed, H.
    Makhlouf, Y.
    Boussaa, H.
    Ouenniche, K.
    Souabni, L.
    Kassab, S.
    Chekili, S.
    Ben Abdelghani, K.
    Fazaa, A.
    Laatar, A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S447 - S447
  • [10] Predictors of effectiveness of biologic disease-modifying antirheumatic drugs (bDMARD) in the treatment of psoriatic arthritis
    Brandao, Natalia Dias
    Morgado, Marina
    Oliveira, Gerusa A.
    Acurcio, Francisco de Assis
    Guerra Junior, Augusto Afonso
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 170 - 171
12345